Mike Polark
Stock Analyst at Baird
(3.61)
# 839
Out of 5,090 analysts
79
Total ratings
50.98%
Success rate
7.6%
Average return
Main Sectors:
Stocks Rated by Mike Polark
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INSP Inspire Medical Systems | Maintains: Outperform | $125 → $180 | $138.35 | +30.10% | 9 | Dec 4, 2025 | |
| EW Edwards Lifesciences | Upgrades: Peer Perform | n/a | $87.63 | - | 5 | Oct 29, 2025 | |
| IRTC iRhythm Technologies | Maintains: Outperform | $180 → $220 | $180.97 | +21.57% | 9 | Oct 10, 2025 | |
| MDT Medtronic | Upgrades: Peer Perform | n/a | $102.23 | - | 3 | Jun 30, 2025 | |
| BBNX Beta Bionics | Initiates: Outperform | $20 | $29.27 | -31.67% | 1 | May 30, 2025 | |
| LIVN LivaNova | Upgrades: Outperform | $60 | $63.76 | -5.90% | 9 | May 20, 2025 | |
| PODD Insulet | Upgrades: Outperform | $350 | $309.75 | +12.99% | 4 | May 13, 2025 | |
| KMTS Kestra Medical Technologies | Initiates: Outperform | $29 | $24.47 | +18.51% | 1 | Mar 31, 2025 | |
| RMD ResMed | Downgrades: Underperform | $180 | $255.86 | -29.65% | 5 | Sep 18, 2024 | |
| ZBH Zimmer Biomet Holdings | Initiates: Peer Perform | n/a | $94.39 | - | 1 | Sep 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $405 | $365.83 | +10.71% | 1 | Sep 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $487 → $503 | $571.61 | -12.00% | 7 | Jul 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Peer Perform | n/a | $125.76 | - | 4 | Jul 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Peer Perform | n/a | $120.14 | - | 3 | Apr 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $121 | $66.48 | +82.01% | 1 | Jan 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $21.09 | - | 1 | Jan 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $25 | $16.59 | +50.69% | 4 | Jan 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $165 | $143.43 | +15.04% | 3 | Sep 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $98.45 | - | 2 | Jul 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $13 | $16.82 | -22.71% | 2 | Apr 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | $21 | $4.81 | +336.59% | 1 | Apr 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $230 → $250 | $262.72 | -4.84% | 2 | Aug 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $43 | $0.70 | +6,045.49% | 1 | Sep 2, 2020 |
Inspire Medical Systems
Dec 4, 2025
Maintains: Outperform
Price Target: $125 → $180
Current: $138.35
Upside: +30.10%
Edwards Lifesciences
Oct 29, 2025
Upgrades: Peer Perform
Price Target: n/a
Current: $87.63
Upside: -
iRhythm Technologies
Oct 10, 2025
Maintains: Outperform
Price Target: $180 → $220
Current: $180.97
Upside: +21.57%
Medtronic
Jun 30, 2025
Upgrades: Peer Perform
Price Target: n/a
Current: $102.23
Upside: -
Beta Bionics
May 30, 2025
Initiates: Outperform
Price Target: $20
Current: $29.27
Upside: -31.67%
LivaNova
May 20, 2025
Upgrades: Outperform
Price Target: $60
Current: $63.76
Upside: -5.90%
Insulet
May 13, 2025
Upgrades: Outperform
Price Target: $350
Current: $309.75
Upside: +12.99%
Kestra Medical Technologies
Mar 31, 2025
Initiates: Outperform
Price Target: $29
Current: $24.47
Upside: +18.51%
ResMed
Sep 18, 2024
Downgrades: Underperform
Price Target: $180
Current: $255.86
Upside: -29.65%
Zimmer Biomet Holdings
Sep 10, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $94.39
Upside: -
Sep 10, 2024
Initiates: Outperform
Price Target: $405
Current: $365.83
Upside: +10.71%
Jul 19, 2024
Maintains: Outperform
Price Target: $487 → $503
Current: $571.61
Upside: -12.00%
Jul 21, 2023
Upgrades: Peer Perform
Price Target: n/a
Current: $125.76
Upside: -
Apr 26, 2023
Downgrades: Peer Perform
Price Target: n/a
Current: $120.14
Upside: -
Jan 26, 2023
Initiates: Outperform
Price Target: $121
Current: $66.48
Upside: +82.01%
Jan 26, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $21.09
Upside: -
Jan 11, 2023
Upgrades: Outperform
Price Target: $25
Current: $16.59
Upside: +50.69%
Sep 15, 2022
Upgrades: Outperform
Price Target: $165
Current: $143.43
Upside: +15.04%
Jul 6, 2022
Initiates: Outperform
Price Target: n/a
Current: $98.45
Upside: -
Apr 6, 2022
Initiates: Outperform
Price Target: $13
Current: $16.82
Upside: -22.71%
Apr 6, 2022
Initiates: Peer Perform
Price Target: $21
Current: $4.81
Upside: +336.59%
Aug 11, 2021
Maintains: Outperform
Price Target: $230 → $250
Current: $262.72
Upside: -4.84%
Sep 2, 2020
Initiates: Neutral
Price Target: $43
Current: $0.70
Upside: +6,045.49%